Confluence Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,188,864
| Closed | -$129M | – | 318 |
|
|
2021
Q4 | $129M | Sell |
2,188,864
-9,992
| -0.5% | -$495K | 1.72% | 14 |
|
|
2021
Q3 | $94.6M | Sell |
2,198,856
-814
| -0% | -$36.1K | 1.33% | 29 |
|
|
2021
Q2 | $86.1M | Buy |
2,199,670
+26,033
| +1% | +$1.01M | 1.14% | 33 |
|
|
2021
Q1 | $78.8M | Sell |
2,173,637
-3,921
| -0.2% | -$139K | 1.11% | 36 |
|
|
2020
Q4 | $80.2M | Sell |
2,177,558
-200,789
| -8% | -$7.37M | 1.19% | 29 |
|
|
2020
Q3 | $82.8M | Sell |
2,378,347
-76,059
| -3% | -$2.67M | 1.35% | 23 |
|
|
2020
Q2 | $76.1M | Sell |
2,454,406
-63,821
| -3% | -$2.17M | 1.27% | 27 |
|
|
2020
Q1 | $78M | Buy |
2,518,227
+118,509
| +5% | +$4.04M | 1.48% | 24 |
|
|
2019
Q4 | $98.6M | Sell |
2,399,718
-30,909
| -1% | -$1.1M | 1.58% | 21 |
|
|
2019
Q3 | $82.9M | Buy |
2,430,627
+30,909
| +1% | +$1.12M | 1.29% | 32 |
|
|
2019
Q2 | $98.6M | Sell |
2,399,718
-1,090
| -0% | -$43.3K | 1.58% | 21 |
|
|
2019
Q1 | $96.7M | Sell |
2,400,808
-93,190
| -4% | -$3.73M | 1.63% | 21 |
|
|
2018
Q4 | $103M | Sell |
2,493,998
-15,791
| -0.6% | -$656K | 1.94% | 12 |
|
|
2018
Q3 | $105M | Sell |
2,509,789
-79,066
| -3% | -$3.04M | 1.79% | 15 |
|
|
2018
Q2 | $89.1M | Sell |
2,588,855
-6,954
| -0.3% | -$238K | 1.57% | 26 |
|
|
2018
Q1 | $87.4M | Buy |
2,595,809
+62,260
| +2% | +$2.14M | 1.61% | 23 |
|
|
2017
Q4 | $87.1M | Buy |
2,533,549
+75,628
| +3% | +$2.58M | 1.59% | 24 |
|
|
2017
Q3 | $83.3M | Buy |
2,457,921
+101,769
| +4% | +$3.27M | 1.59% | 22 |
|
|
2017
Q2 | $75.1M | Buy |
2,356,152
+167,883
| +8% | +$5.29M | 1.53% | 30 |
|
|
2017
Q1 | $71M | Buy |
2,188,269
+217,387
| +11% | +$6.85M | 1.58% | 26 |
|
|
2016
Q4 | $60.7M | Buy |
1,970,882
+159,932
| +9% | +$4.88M | 1.47% | 27 |
|
|
2016
Q3 | $58.2M | Buy |
1,810,950
+153,371
| +9% | +$5.13M | 1.52% | 27 |
|
|
2016
Q2 | $55.4M | Buy |
1,657,579
+147,993
| +10% | +$4.72M | 1.52% | 21 |
|
|
2016
Q1 | $42.5M | Buy |
1,509,586
+95,121
| +7% | +$2.72M | 1.27% | 34 |
|
|
2015
Q4 | $43.3M | Buy |
1,414,465
+77,613
| +6% | +$2.44M | 1.42% | 26 |
|
|
2015
Q3 | $39.8M | Buy |
1,336,852
+48,212
| +4% | +$1.55M | 1.45% | 23 |
|
|
2015
Q2 | $41M | Buy |
1,288,640
+62,608
| +5% | +$2.04M | 1.49% | 20 |
|
|
2015
Q1 | $40.5M | Buy |
1,226,032
+61,792
| +5% | +$1.96M | 1.53% | 20 |
|
|
2014
Q4 | $34.4M | Buy |
1,164,240
+63,623
| +6% | +$1.82M | 1.4% | 26 |
|
|
2014
Q3 | $30.9M | Buy |
1,100,617
+60,031
| +6% | +$1.68M | 1.38% | 27 |
|
|
2014
Q2 | $29.3M | Buy |
1,040,586
+67,401
| +7% | +$1.92M | 1.34% | 29 |
|
|
2014
Q1 | $29.7M | Buy |
973,185
+72,312
| +8% | +$2.16M | 1.5% | 18 |
|
|
2013
Q4 | $26.2M | Buy |
900,873
+77,542
| +9% | +$2.26M | 1.45% | 21 |
|
|
2013
Q3 | $22.4M | Buy |
823,331
+74,970
| +10% | +$2.04M | 1.39% | 24 |
|
|
2013
Q2 | $19.9M | Buy |
+748,361
| New | +$20.7M | 1.37% | 21 |
|
Other funds holding PFE
Confluence Investment Management's PFE Position: Q1 2022 in Review
Confluence Investment Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 2,188,864 shares — an estimated $129M sold.
Confluence Investment Management first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $129M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Confluence Investment Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
- Confluence Investment Management sold 2,188,864 Pfizer shares in Q1 2022, an estimated $129M.
- Confluence Investment Management first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
- Confluence Investment Management's Pfizer position peaked at $129M in Q4 2021.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Confluence Investment Management's 13F filing for Q1 2022, filed 4 Apr 2022.